Put companies on watchlist
Krones AG
ISIN: DE0006335003
WKN: 633500
Curious about what AI knows about Krones? Just one click more
More AI Integrations
About
Company Snapshot
New: Enable Investor Alerts
Be informed about new publications
New: AI Factsheet

Corporate News meets AI! 
Content analysis and summary

Krones AG · ISIN: DE0006335003 · EQS - Company News (54 News)
Country: Germany · Primary market: Germany · EQS NID: 1869777
28 March 2024 11:00AM

Krones successfully completes acquisition of injection molding technology company Netstal


EQS-News: Krones AG / Key word(s): Miscellaneous
Krones successfully completes acquisition of injection molding technology company Netstal

28.03.2024 / 11:00 CET/CEST
The issuer is solely responsible for the content of this announcement.


Corporate News Release

 

28 March 2024

 

Krones successfully completes acquisition of injection molding technology company Netstal
 

In the press release dated 7 February 2024, Krones announced the signing of the contract for the acquisition of 100% of the shares in Netstal Maschinen AG (Netstal), based in Näfels, Switzerland. The acquisition remained subject among other things to regulatory approval. Krones has now received that approval with no conditions. The acquisition of the injection molding technology company is thus final. Krones will consolidate Netstal in the Filling and Packaging Technology segment as from 28 March 2024. In the financial year 2023, Netstal generated revenue of more than €200 million with around 560 employees. Netstal’s operating profitability is currently below that of the Krones Group.

Netstal acquisition a significant strategic milestone

As a leading supplier of injection moulding machines for the beverage market (PET preforms and closures), Netstal is a perfect strategic fit for Krones. For one thing, the acquisition will enable the company to provide additional innovative products, technologies and services. In addition, following the acquisition of Netstal, Krones now has all technologies required for circular PET solutions – from injection moulding of preforms to PET bottle production and from filling and packaging to used bottle recycling.

With its injection moulding technology for medical applications and thin-wall packaging, Netstal also supports Krones’ strategy of diversifying into the medical/pharmaceutical market and into the food and body care sectors.

Netstal will continue to manage its business self-responsible, while benefiting from the Krones Group’s international positioning and economies of scale. This and other measures will help to improve Netstal’s profitability and raise it to the level of the Krones Group in the medium term.

 

Contact:

Olaf Scholz
Head of Investor Relations, Krones AG
Phone: +49 9401 70 1169
Email: olaf.scholz@krones.com



28.03.2024 CET/CEST Dissemination of a Corporate News, transmitted by EQS News - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.eqs-news.com


Language: English
Company: Krones AG
Böhmerwaldstraße 5
93073 Neutraubling
Germany
Phone: +49 (0)9401 701169
Fax: +49 (0)9401 709 1 1169
E-mail: investor-relations@krones.com
Internet: www.krones.com
ISIN: DE0006335003
WKN: 633500
Indices: MDAX
Listed: Regulated Market in Frankfurt (Prime Standard), Munich; Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Hanover, Stuttgart, Tradegate Exchange
EQS News ID: 1869777

 
End of News EQS News Service

1869777  28.03.2024 CET/CEST

fncls.ssp?fn=show_t_gif&application_id=1869777&application_name=news&site_id=boersengefluester~~~ace3d64b-2049-452a-8d18-fbc8044c4b5f
Visual performance / price development - Krones AG
Smart analysis and research tools can be found here.
MIC: XETR

This publication was provided by our content partner EQS3.

EQS Newswire
via EQS - Newsfeed
EQS Group AG ©2025
(DGAP)
Contact:
Karlstraße 47 D-80333 München
+49 (0) 89 444 430-000

P R O D U C T   S U G G E S T I O N S

The information presented here has been provided by our content partner EQS-Group. The originator of the news is the respective issuer, the company relating to the news, a publication service provider (press or information agency) which uses the distribution service of EQS to transmit company news to shareholders, investors, investors or interested parties. The original publications and other company-relevant information can be found at eqs-news.com.


The information you can access does not constitute investment advice. The presentation of our cooperation partners, where the implementation of investment decisions would be possible depending on the individual risk profile, is solely at the discretion of the person using the service. We only present companies of which we are convinced that the range of services and customer service will satisfy discerning investors.

If you are considering leverage products, familiarise yourself with the typical characteristics of the financial instruments beforehand. Take the time to determine the risk content of the planned investment before making an investment decision. Bear in mind that a total loss cannot be ruled out with leverage products.

For newcomers to the subject, we offer various options in both the training and the tools section, through which you can train theoretical knowledge and practical experience and thus improve your skills. The offer ranges from participation in webinars to personal mentoring. The range is continuously being expanded.


1 Lab features are usually functionalities that emerge from the think tank of the investor community. In the early stages, these are experimental functionalities whose development process is largely determined by use and the resulting feedback from the community. When integrating external services or functionalities, the functionality can only be guaranteed to the extent that the individual process elements, such as interfaces, interact with each other.